Principal Accounting Officer Cyril Allouche sold $52K of Revance Therapeutics, Inc.

Sold$51,899

$23.72Price

2,188Shares

−32%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Fri, Nov 9. Filed Fri, Nov 9, 3:59 PM ET, during the session. Not investment advice.